3 completed, 3 unknown, 1 recruiting. 3 Not applicable, 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 2, Unknown 1 |
| Early Phase 1 | 1 | Completed 1 |
Follow Controls: new trials by email Literature Review of Controls trials Research Report on Controls
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| QUANTIFY: Quantitative Understanding of Advanced Novel Techniques for Imaging Fasciitis and Yielding Biomarkers Clinical exam, Ultrasound imaging, Magnetic Resonance Imaging - Plantar Fasciopathy, Achilles Tendinopathy | Not applicable | Completed | Ruth Chimenti | 106 | 2025-05-22 | 2026-07-02 |
| Test-retest Reliability and Agreement of Trunk Muscle Activation in Pain-free Persons No intervention - Controls, Healthy Control | Recruiting | University Ghent | 18 | 2024-04-02 | 2025-05-16 | |
| Sequelae of COVID-19 With Focus on Exercise Capacity and Underlying Mechanisms Cardiorespiratory fitness, Lung function, Muscular strength and balance tests - Patients Post-COVID-19, Controls | Unknown | Arno Schmidt-Trucksäss | 128 | 2023-01-03 | 2023-02-10 | |
| A Mobile App to Improve Participation in Following-up Cohorts RECAP_MyLife mobile app, Usual data collection methods - Participants of Longitudinal Cohort Studies, Controls | Not applicable | Unknown | Instituto de Saude Publica da Universidade do Porto | 310 | 2021-02-01 | 2021-01-19 |
| Serum Neurofilaments and GFAP in Atypical Multiple Sclerosis Blood withdrawal, MRI, Neurologic / neuropsychologic tests - Patients - Relapsing Remitting Multiple Sclerosis, Progressive Multiple Sclerosis | Not applicable | Completed | University Hospital, Montpellier | 58 | 2019-12-09 | 2025-09-30 |
| Validating a New Non-invasive Approach to Testing Lidocaine Effectiveness Lidocaine gel, Placebo, Injected lidocaine - ADHD, Controls | Early Phase 1 | Completed | PhenoSolve, LLC | 20 | 2019-08-01 | 2020-07-15 |
| Traumatic Brain Injury Feasibility Study (EPIC-011) ClearView Scanning - Traumatic Brain Injury, Controls | Unknown | Epic Research & Diagnostics, Inc. | 200 | 2015-04-01 | 2015-11-20 |
Attention Deficit Disorder with Hyperactivity (1) · Brain Injuries, Traumatic (1) · Coronavirus Infections (1) · Fasciitis, Plantar (1) · Multiple Sclerosis (1) · Multiple Sclerosis, Chronic Progressive (1) · Multiple Sclerosis, Relapsing-Remitting (1) · Pain (1)
Nervous System Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Attention Deficit and Disruptive Behavior Disorders (1) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Brain Diseases (1) · Brain Injuries (1) · Central Nervous System Diseases (1) · Chronic Disease (1) · Coronaviridae Infections (1) · Craniocerebral Trauma (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Disease Attributes (1) · Fasciitis (1)
Blood Specimen Collection (1) · Body Composition (1) · Cardiorespiratory Fitness (1) · Exercise (1) · Magnetic Resonance Imaging (1) · Methods (1) · Respiration (1) · Ultrasonography (1)
Arno Schmidt-Trucksäss (1) · Epic Research & Diagnostics, Inc. (1) · Instituto de Saude Publica da Universidade do Porto (1) · PhenoSolve, LLC (1) · Ruth Chimenti (1) · University Ghent (1) · University Hospital, Montpellier (1)
United States (3) · Belgium (1) · France (1) · Switzerland (1)
Henrique Barros, Professor (1) · James Holmes, PhD (1) · Kathleen Sluka, PT, PhD (1) · Lieven Danneels, Professor (1) · Michael Segal, MD PhD (1) · Ruth L Chimenti, PT, PhD (1)
PMID 11143733, PMID 18174562, PMID 18426576, PMID 23134619, PMID 24938135, PMID 25447751, PMID 41672492, PMID 9212254
R61AT012275 (1)